Profile
Richard B. Doubleday is currently a Director at CeQur SA. Prior to this, he was the Chief Commercial Officer & Executive VP at DexCom, Inc. from 2015 to 2020.
He was also the Director-Brand Marketing at Animas LLC from 2006 to 2009 and the Director-Field Sales at Lifescan, Inc. in 2005.
Mr. Doubleday received his undergraduate degree from Michigan State University.
Richard B. Doubleday active positions
| Companies | Position | Start |
|---|---|---|
CeQur SA
CeQur SA Medical SpecialtiesHealth Technology Develops medical devices for diabetes patients | Director/Board Member | 2021-06-24 |
Former positions of Richard B. Doubleday
| Companies | Position | End |
|---|---|---|
| DEXCOM, INC. | Corporate Officer/Principal | 2020-12-30 |
Animas LLC
Animas LLC Medical SpecialtiesHealth Technology Manufactures and distributes external insulin pumps for diabetes patients | Sales & Marketing | 2009-05-31 |
Lifescan, Inc.
Lifescan, Inc. Medical/Nursing ServicesHealth Services Manufactures health care products | Sales & Marketing | 2005-09-30 |
Training of Richard B. Doubleday
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Animas LLC
Animas LLC Medical SpecialtiesHealth Technology Manufactures and distributes external insulin pumps for diabetes patients | Health Technology |
Michigan State University
Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DexCom, Inc.
DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
Lifescan, Inc.
Lifescan, Inc. Medical/Nursing ServicesHealth Services Manufactures health care products | Health Services |
CeQur SA
CeQur SA Medical SpecialtiesHealth Technology Develops medical devices for diabetes patients | Health Technology |
- Stock Market
- Insiders
- Richard B. Doubleday
















